calendar
29,501 catalysts · 10,013 approval · 5,000 device 510k · 4,728 grant · 2,629 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
29,501 catalysts · 10,013 approval · 5,000 device 510k · 4,728 grant · 2,629 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: NALPROPION. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: ANIMA. Form: SYRUP. Route: ORAL
Sponsor: ANIMA. Form: SYRUP. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: SUBLINGUAL
Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: SPRAY, METERED. Route: NASAL
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: SPRAY, METERED. Route: NASAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: RISING. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL
Sponsor: ABBVIE INC. Form: VIAL
Sponsor: RHODES PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION